Federal Court dismisses action alleging patent infringement by new Apotex heartburn drug

By Karunjit Singh (February 12, 2024, 11:33 AM EST) -- The Federal Court has dismissed claims that a new Apotex drug infringes a patent, finding the asserted claims as invalid and not infringed by the new drug....
LexisNexis® Research Solutions

Documents

Related Sections